- Joined
- Feb 27, 2004
- Messages
- 2,641
- Reaction score
- 757
PNN Pharmacotherapy Line
Oct. 18, 2007 * Special alert
Providing news and information about medications and their proper use
Pfizer announced this morning plans to discontinue sales of inhaled insulin (Exubera) over the next 3 months, citing poor acceptance by patients and physicians. In a news release announcing the company's third-quarter financial results, Jeff Kindler, Chairman and Chief Executive Officer, was quoted as saying, Despite our best efforts, Exubera has failed to gain the acceptance of patients and physicians. We have therefore concluded that further investment in this product is unwarranted. We will work with physicians to transition Exubera patients to other treatment options in the next 3 months. We remain committed to investing significant resources in the development of new and innovative medicines to manage diabetes, including monitoring inhalation technologies and other innovative delivery systems for insulin and other medicines.
Can't say I'm surprised. That was the most awkward, hard to use system. I don't know how it helped people with needle-phobia when you still needed to test glucose and use a basal insulin injection
Hope something better comes along soon.
Oct. 18, 2007 * Special alert
Providing news and information about medications and their proper use
Pfizer announced this morning plans to discontinue sales of inhaled insulin (Exubera) over the next 3 months, citing poor acceptance by patients and physicians. In a news release announcing the company's third-quarter financial results, Jeff Kindler, Chairman and Chief Executive Officer, was quoted as saying, Despite our best efforts, Exubera has failed to gain the acceptance of patients and physicians. We have therefore concluded that further investment in this product is unwarranted. We will work with physicians to transition Exubera patients to other treatment options in the next 3 months. We remain committed to investing significant resources in the development of new and innovative medicines to manage diabetes, including monitoring inhalation technologies and other innovative delivery systems for insulin and other medicines.
Can't say I'm surprised. That was the most awkward, hard to use system. I don't know how it helped people with needle-phobia when you still needed to test glucose and use a basal insulin injection
Hope something better comes along soon.